HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carmen Veríssima Ferreira-Halder Selected Research

Therapeutics

1/2020Vemurafenib downmodulates aggressiveness mediators of colorectal cancer (CRC): Low Molecular Weight Protein Tyrosine Phosphatase (LMWPTP), Protein Tyrosine Phosphatase 1B (PTP1B) and Transforming Growth Factor β (TGFβ).
10/2015(-)-Tarchonanthuslactone: Design of New Analogues, Evaluation of their Antiproliferative Activity on Cancer Cell Lines, and Preliminary Mechanistic Studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carmen Veríssima Ferreira-Halder Research Topics

Disease

4Neoplasms (Cancer)
02/2021 - 10/2015
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2020 - 12/2013
2Neoplasm Metastasis (Metastasis)
01/2020 - 02/2015
1Stomach Neoplasms (Stomach Cancer)
01/2021
1Colorectal Neoplasms (Colorectal Cancer)
01/2020
1Wounds and Injuries (Trauma)
01/2020
1Adenocarcinoma
04/2019
1Adenocarcinoma of Lung
04/2019
1Prostatic Neoplasms (Prostate Cancer)
02/2015
1Melanoma (Melanoma, Malignant)
02/2015
1Sarcoma (Soft Tissue Sarcoma)
02/2015
1Lymphoma (Lymphomas)
02/2015
1Leukemia
02/2015
1Kidney Neoplasms (Kidney Cancer)
02/2015
1Renal Cell Carcinoma (Grawitz Tumor)
02/2015
1Hypoxia (Hypoxemia)
11/2014
1Carcinoma (Carcinomatosis)
12/2013
1Retinoblastoma (Glioblastoma, Retinal)
12/2013

Drug/Important Bio-Agent (IBA)

4Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2020 - 12/2013
3Protein Tyrosine PhosphatasesIBA
02/2021 - 01/2020
2calix(6)areneIBA
01/2020 - 12/2013
2Phosphotransferases (Kinase)IBA
02/2015 - 12/2013
2Proteins (Proteins, Gene)FDA Link
11/2014 - 12/2013
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
02/2021
1EnzymesIBA
02/2021
1Tyrosine (L-Tyrosine)FDA Link
02/2021
1CarcinogensIBA
01/2021
16-pyruvoyltetrahydropterin synthase (PTPS)IBA
01/2021
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2020
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2020
1VemurafenibIBA
01/2020
1Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA
01/2020
1XylansIBA
04/2019
18- (4- carboxymethyloxy)phenyl- 1,3- dipropylxanthineIBA
04/2019
1catechol (pyrocatechol)IBA
10/2015
1acrylic acid (acrylate)IBA
10/2015
1tarchonanthuslactoneIBA
10/2015
1PyransIBA
10/2015
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2015
1Fas Ligand Protein (Fas Ligand)IBA
02/2015
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
02/2015
1PhosphotyrosineIBA
02/2015
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
02/2015
1Avian ProteinsIBA
02/2015
1Type I Tumor Necrosis Factor ReceptorsIBA
02/2015
1TNF Receptor-Associated Factor 2 (TRAF2)IBA
02/2015
1p38 Mitogen-Activated Protein KinasesIBA
02/2015
1Apoptosis Inducing FactorIBA
02/2015
1Caveolin 1IBA
02/2015
1Phosphoprotein Phosphatases (Phosphatases, Protein)IBA
02/2015
1Protein Kinases (Protein Kinase)IBA
02/2015
1Riboflavin (Vitamin B2)FDA LinkGeneric
02/2015
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
02/2015
1IgA receptor (protein B)IBA
02/2015
1goniothalaminIBA
11/2014
1Mitogen-Activated Protein KinasesIBA
11/2014
1Cyclin D1IBA
11/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2014
1Transcription Factors (Transcription Factor)IBA
11/2014
1Calixarenes (Calixarene)IBA
12/2013
1tyrosine receptor (receptor, tyrosine)IBA
12/2013
1Pharmaceutical PreparationsIBA
12/2013

Therapy/Procedure

2Therapeutics
01/2020 - 10/2015
1Drug Therapy (Chemotherapy)
02/2015